There will be a slight slowdown in the annual rate of growth in retail current value sales of paediatric consumer health in 2025. In Algeria, there is a noticeable shift in consumer preferences from traditional remedies to modern medical treatments, and this is particularly the case in paediatric healthcare. Meanwhile, Algerian parents, even those facing financial constraints, continue to prioritise their children’s health and are willing to pay higher prices for products that ensure their wellb

Value sales are rising within paediatric consumer health in the Philippines in 2025. Parents - especially mothers - are becoming more conscious about children's health as social occasions and flu cases increase. Younger mothers account for most purchases within paediatric vitamins. Previously, parents were interested only in vitamin C for their children, but now mothers – especially younger ones - are purchasing a range of vitamins and dietary supplements amid rising caution about children’s hea

Value sales of paediatric consumer health are rising in New Zealand in 2025, driven by uptake of both established and emerging products that address children's health needs - particularly regarding immunity, skin health and allergy relief. Paediatric vitamins and dietary supplements represents the vast majority of the paediatric consumer health category and increased its value share over the review period, leading value growth in 2025.

Profit margins are expected to fall in 2025. While current value sales increase, constant value sales fall. Unit prices remain unchanged, following a decision by the Tunisian Ministry of Health to freeze prices across the pharmaceutical sector after notable prices increases in 2024. This impacts profit margins for many products within paediatric consumer health. While paediatric analgesics continue to account for most value sales, paediatric vitamins and dietary supplements are expected to regis

Value sales of paediatric consumer health in Nigeria continue to rise in 2025, supported by the essential nature of the category and a gradual stabilisation of inflation. With prices increasing at a slower pace than in 2024, volume sales are showing recovery. Despite continued economic pressures, the category benefits from parents’ strong commitment to maintaining their children’s health and wellbeing.

Value sales of paediatric consumer health are increasing in 2025, amid new national initiatives promoting children’s health and wellbeing. In January 2025, the Singapore government launched the Grow Well SG scheme, designed to instil healthy habits among children in Primary 1 to 3 through personalised health plans. The programme focuses on reducing sedentary behaviour, limiting screen time and encouraging regular outdoor activity, reinforcing parents’ awareness of preventive health.

Value sales of paediatric consumer health continued to grow in 2025. Despite a decline in purchasing power caused by ongoing economic challenges, consumers continued to prioritise their children’s health and remained committed to purchasing healthcare products for them. However, many shifted towards more affordable options, including generic brands, as cost-effectiveness became increasingly important. As a result, premium-priced imported products faced growing pressure.

Paediatric consumer health in Spain is projected to see a moderate-to-good increase in retail current value sales over 2025, only slightly slower than in 2024. The category has long been challenged by a gradual decrease in the birth rate, although stabilisation was observed towards the end of the review period. Indeed, there is projected to be a small increase in the birth rate (per ‘000 population) in 2025. This supports, to some extent, the performance of paediatric consumer health.

In 2025, paediatric consumer health in Italy recorded strong growth, driven mainly by the impact of a particularly intense and long-lasting flu season. Influenza had a direct effect not only on demand for specific products for the prevention and treatment of symptoms but also generated a significant boost in related categories such as paediatric antipyretics and cough suppressants, which benefited from an increase in self-medication by parents. The driving effect of flu was also reflected in gre

Paediatric consumer health in Ireland saw modest growth in 2025, largely fuelled by analgesics and vitamins. With limited access to GPs and a growing emphasis on self-care, Irish parents increasingly turned to over-the-counter solutions for treating minor ailments. Additionally, seasonal illnesses and the influence of social media trends further boosted demand for paediatric products.

Paediatric consumer health in South Africa is projected to see further strong retail current value sales growth over 2025, largely in line with the 2024 performance. Despite strong economic challenges, not least rising unit prices, paediatric consumer health is seeing increased demand at the end of the review period. Parents in South Africa continue to prioritise their children's health and wellbeing, driving category growth in the midst of inflationary pressure on prices and related constrained

Paediatric consumer health in North Macedonia has continued to expand at an impressive pace in current value terms in 2025. Despite falling birth rates, overall demand remains robust thanks to rising health awareness. This trend is giving parents greater confidence when it comes to self-medication, and means they increasingly recognise that aside from being safer, products specifically formulated for children are typically more effective than giving them reduced doses of those that are primarily

Sales of paediatric consumer health have seen moderate growth in current value terms in 2025. However, performances have varied across the different categories. Paediatric cough, cold and allergy (hay fever) remedies has been the most dynamic category, with sales benefiting from a tough cold and flu season in winter 2024/2025, with France being hit by several flu strains as well as a new strain of COVID-19. The category has also benefited from the desire from parents to ensure their children rec

Retail value sales of paediatric consumer health are expected to increase in current term in Indonesia in 2025, supported by a growing population of health-aware parents and persistent concerns over infectious diseases in school and daycare environments. Recovery from earlier pandemic disruptions and the full return to in-person schooling has brought paediatric health back to the top of the household agenda, prompting parents to seek both preventive and symptom-relieving remedies.

Value sales for paediatric consumer health in Saudi Arabia continues to rise in 2025 as parents remain highly attentive to their children’s wellbeing. Weak immunity among children post-pandemic, combined with the country’s harsh climate conditions and frequent exposure to seasonal viruses in nurseries, schools and daycare centres, has heightened demand for preventive and treatment options. The return of large-scale leisure, entertainment and gatherings has also increased exposure to illnesses, r

Paediatric consumer health in Hong Kong is enjoying robust rises in terms of value sales in 2025, partly in response to heightened awareness during influenza season. As the city grapples with ongoing waves of influenza, hay fever and emerging variants of COVID-19, there is a growing recognition among parents and caregivers of the importance of having effective paediatric cough and cold remedies, as well as paediatric analgesics, readily available to combat these illnesses.

Sales of paediatric consumer health have seen strong growth in current value terms in 2025. The category has benefited from increasing parental awareness of children's nutrition and health, especially in urban areas. There has also been an increasing demand for paediatric vitamins and dietary supplements, and immunity-supporting products in Thailand, with busy families looking for convenient ways to ensure their children receive a complete nutrition. Despite this, Thailand’s birth rate is fallin

The rate of growth in retail current value sales of paediatric consumer health slowed but remained in double digits in Uzbekistan during 2025. This growth was driven by rising parental interest in paediatric health, the rising number of children aged 0-12, improved healthcare access, and the greater availability of child-friendly products. The essential nature of these remedies also helped to protect the category from broader market challenges. Paediatric cough, cold, and allergy remedies repres

Value sales of paediatric consumer health products increased in Greece in 2025, driven largely by price rises. However, self-medication remained low in the category, as most parents are reluctant to use products on their children, before consulting a paediatrician.

There is expected to be muted current value growth in paediatric consumer health in Portugal in 2025. That being said, there continues to be product innovation, with a focus on formats, with more prevalence of chewable tablets and gummies. Paediatric cough, cold and allergy remedies are expected to register the highest value growth. Widespread cough and cold in the winter months support cough and cold remedies, while increasing pollution and longer pollen seasons, due to climate change, supports

Paediatric consumer health consumption in Uruguay is expected to continue growing in current value terms in 2025. This is supported by the preventive health trend, with increasing penetration among middle-income households who are more focused on their children’s overall health and wellbeing. Paediatric analgesics is projected to remain the largest category, with paediatric acetaminophen showing an especially dynamic performance, driven by its widespread use for mild fever and pain management, a

Value sales of paediatric consumer health in Malaysia are on the up in 2025, supported by robust demand in paediatric vitamins and dietary supplements, nappy (diaper) rash treatments and cough/cold remedies. Parents remain highly selective and are willing to spend on premium products for their children. Imported brands such as Mustela Baby, Earth Mama Organic Diaper Balm and QV Baby are gaining ground, helping sustain value growth despite wider cost-of-living pressures.

Paediatric consumer health has seen positive growth in current value terms in 2025. This growth has been partly driven by marketing efforts from manufacturers and a surge in new product launches targeting children. Manufacturers are also enhancing product formats to appeal to children, making them more palatable and user-friendly. Gummies, for example, are proving increasingly popular in vitamins and dietary supplements.

Paediatric consumer health in Slovakia is recording moderate retail value growth in 2025, recovering after a sharp decline in the previous year. The rebound is being propelled by improving availability of paediatric analgesics and digestive remedies, which are posting solid gains. Paediatric vitamins and dietary supplements are also growing, reflecting a strong preventive health trend, while nappy rash treatments continue to hold a significant share despite the country’s declining birth rate.